百部根低分子量多糖的抗炎活性及其针对脓毒症引起的急性肺损伤的潜在机制。
Anti-inflammatory activity and underlying mechanism against sepsis-induced acute lung injury of a low-molecular-weight polysaccharide from the root of Stemona tuberosa Lour.
发表日期:2024 Oct 17
作者:
Xiang Qiu, Yan Geng, Xiaoyue Cai, Yanghui Ou, Mengjie Li, Yali Zhang, Dengqin He, Xudong Qian, Yanting Wu, Hongwei Ma, Jing-Kun Yan, Hongliang Yao, Wen-Hua Chen
来源:
Int J Biol Macromol
摘要:
百部 (Stemona tuberosa Lour) 的根已用于治疗肺结核、疥疮和湿疹。多糖是其主要生物活性成分之一。通过优化三相分配从马铃薯根中获得低分子量(1819Da)多糖(SPS2-A),并采用离子色谱柱纯化,并对其作用和机制进行了研究。结构分析表明,SPS2-A 含有阿拉伯糖、半乳糖 (Gal)、葡萄糖 (Glc)、木糖和甘露糖。 SPS2-A主链结构包含糖残基→4)-α-D-Glcp-(1→,→4)-α-D-Galp-(1→,和→4,6)-β-D-Galp- (1→,而侧链主要由α-D-Glcp-(1→连接到残基→4,6)-β-D-Galp-(1→。体外,SPS2- A 下调脂多糖诱导的 RAW264.7 巨噬细胞中白细胞介素 6 的表达 在体内,SPS2-A 显着下调支气管肺泡灌洗液和肺中髓过氧化物酶、白细胞介素 6、白细胞介素 1β 和肿瘤坏死因子 α 的表达。蛋白质印迹分析表明,SPS2-A 通过激活核因子 κB 通路,减轻脓毒症引起的急性肺损伤小鼠的肺部炎症。这些结果表明,SPS2-A 是治疗脓毒症的潜在抗炎候选药物。诱发急性肺损伤。版权所有 © 2024。由 Elsevier B.V. 出版。
The root of Stemona tuberosa Lour has been used to treat tuberculosis, scabies, and eczema. Polysaccharides are among its main bioactive ingredients. A low-molecular-weight (1819 Da) polysaccharide (SPS2-A) was obtained from the root of S. tuberosa Lour by optimizing three-phase partitioning, purified using an ion chromatography column, and its effects and mechanisms were investigated. Structural analysis revealed that SPS2-A contained arabinose, galactose (Gal), glucose (Glc), xylose, and mannose. The SPS2-A backbone structure comprised sugar residues →4)-α-D-Glcp-(1→, →4)-α-D-Galp-(1→, and →4,6)-β-D-Galp-(1→, while the side chain primarily comprised α-D-Glcp-(1 → connected to the O-6 position of the residue →4,6)-β-D-Galp-(1→. In vitro, SPS2-A downregulated the expression of interleukin-6 in lipopolysaccharide-induced RAW264.7 macrophages. In vivo, SPS2-A significantly downregulated the expression of myeloperoxidase, interleukin-6, interleukin-1β, and tumor necrosis factor-α in bronchoalveolar lavage fluid and lung tissue. Western blotting analysis indicated that SPS2-A reduced lung inflammation in mice with sepsis-induced acute lung injury by activating the nuclear factor κB pathway. These results suggest that SPS2-A is a potential anti-inflammatory candidate for the treatment of sepsis-induced acute lung injury.Copyright © 2024. Published by Elsevier B.V.